Founded in 2014, Bionpharma develops, manufactures, markets, and distributes generic prescription and over-the-counter medicines for U.S. and international markets. The company operates a full-scale pharmaceutical platform with research and development capabilities, a manufacturing site in Chennai, India, and more than 50 marketed drugs. Bionpharma is also one of the largest suppliers of softgel capsules in the United States and has sold its A+ Health OTC line through Amazon since 2019.
GMP compliant Quality Control and Stability Lab
compliance_program
GMP compliant warehouse
compliance_program
FDA drug listing and registration
registration
ScieGen PharmaceuticalsFounded in 2009, ScieGen Pharmaceuticals develops and manufactures finished-dose generic medicines, with its products made in the United States at cGMP facilities in Hauppauge, New York. Its Long Island operation spans more than 250,000 square feet and is designed for annual production of over 10 billion tablet and capsule units, supported by formulation and analytical research in Hyderabad, India. The company has filed more than 75 ANDAs and distributes generic drugs across a broad range of therapeutic categories.HAUPPAUGE, NY
Bio-Pharm IncBio-Pharm, Inc. is a leading supplier of generic pharmaceutical formulations, investing heavily in R&D to develop innovative and high-quality pharmaceuticals to improve millions of lives.LEVITTOWN, PA
UnipharmEstablished in 1992, Unipharm is an international group that develops and supplies over-the-counter medicines and nutritional supplements, with products made in America and the European Union. Unipharm Inc. is FDA registered, and the group’s tablets and capsules undergo testing and manufacturing controls aligned with GMP requirements. Its brands are marketed in countries around the world through offices in the USA, Ireland, and elsewhere.CHISINAU, MD
STI Pharma, LLCFounded in 2008 by industry executive Anup Dam, privately owned STI Pharma develops, licenses, acquires and commercializes generic medicines. The company manages product development and regulatory support in-house, while its commercial products are made at FDA-registered partner facilities and distributed across the United States and its territories. STI is particularly active in specialty and injectable generics, including recent launches such as thiotepa and isoproterenol hydrochloride.NEWTOWN, PA